{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T22:10:15Z","timestamp":1790460615550,"version":"4.1.0"},"reference-count":54,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2018,11,27]],"date-time":"2018-11-27T00:00:00Z","timestamp":1543276800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Early diagnosis and treatment of infants with symptomatic congenital cytomegalovirus (CMV) infection may improve neurological outcomes. For this reason, prenatal detection of newborns at high risk for congenital CMV infection is important. A polymerase chain reaction (PCR) assay for CMV DNA in the amniotic fluid is the gold standard for the diagnosis of intrauterine CMV infection; however, amniocentesis is an invasive procedure. Recently, we have found that the presence of CMV DNA in the maternal uterine cervical secretion is predictive of the occurrence of congenital CMV infection in CMV immunoglobulin M (IgM)-positive pregnant women. In contrast, we have suggested that maternal serological screening for primary CMV infection using CMV-specific immunoglobulin G (IgG), the IgG avidity index, or CMV-specific IgM overlooks a number of newborns with congenital CMV infection. We will review current knowledge of the potential biomarkers for predicting congenital CMV infection.<\/jats:p>","DOI":"10.3390\/ijms19123760","type":"journal-article","created":{"date-parts":[[2018,11,27]],"date-time":"2018-11-27T03:31:33Z","timestamp":1543289493000},"page":"3760","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Potential Biomarkers for Predicting Congenital Cytomegalovirus Infection"],"prefix":"10.3390","volume":"19","author":[{"given":"Kenji","family":"Tanimura","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9839-2214","authenticated-orcid":false,"given":"Hideto","family":"Yamada","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2018,11,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1128\/CMR.15.4.680-715.2002","article-title":"Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant","volume":"15","author":"Revello","year":"2002","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1056\/NEJM198511143132006","article-title":"Herpesvirus infections of pregnancy. Part I: Cytomegalovirus and Epstein-Barr virus infections","volume":"313","author":"Stagno","year":"1985","journal-title":"N. Engl. J. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13052-017-0358-8","article-title":"Congenital cytomegalovirus infection: Advances and challenges in diagnosis, prevention and treatment","volume":"43","author":"Marsico","year":"2017","journal-title":"Ital. J. Pediatr."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0022-3476(03)00192-6","article-title":"Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: A randomized, controlled trial","volume":"143","author":"Kimberlin","year":"2003","journal-title":"J. Pediatr."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.braindev.2015.08.003","article-title":"Neurological outcomes in symptomatic congenital cytomegalovirus-infected infants after introduction of newborn urine screening and antiviral treatment","volume":"38","author":"Nishida","year":"2016","journal-title":"Brain Dev."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"S171","DOI":"10.1093\/cid\/cit611","article-title":"Congenital cytomegalovirus infection: An obstetrician\u2019s point of view","volume":"57","author":"Soper","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jcv.2010.12.012","article-title":"Role of prenatal diagnosis and counseling in the management of 735 pregnancies complicated by primary human cytomegalovirus infection: A 20-year experience","volume":"50","author":"Revello","year":"2011","journal-title":"J. Clin. Virol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/infdis\/145.2.647","article-title":"Infection with cytomegalovirus during pregnancy: Specific IgM antibodies as a marker of recent primary infection","volume":"145","author":"Griffiths","year":"1982","journal-title":"J. Infect. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1111\/j.1469-0691.2011.03564.x","article-title":"Update on the prevention, diagnosis and management of cytomegalovirus infection during pregnancy","volume":"17","author":"Lazzarotto","year":"2011","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1128\/JCM.02172-08","article-title":"Evaluation of the new architect cytomegalovirus immunoglobulin M (IgM), IgG, and IgG avidity assays","volume":"47","author":"Lagrou","year":"2009","journal-title":"J. Clin. Microbiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1002\/jmv.23387","article-title":"Low IgG avidity and ultrasound fetal abnormality predict congenital cytomegalovirus infection","volume":"84","author":"Sonoyama","year":"2012","journal-title":"J. Med. Virol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1515\/jpm-2013-0333","article-title":"The IgG avidity value for the prediction of congenital cytomegalovirus infection in a prospective cohort study","volume":"42","author":"Ebina","year":"2014","journal-title":"J. Perinat. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jcv.2015.03.002","article-title":"Rapid increase in the serum cytomegalovirus IgG avidity index in women with a congenitally infected fetus","volume":"66","author":"Ebina","year":"2015","journal-title":"J. Clin. Virol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1093\/cid\/cix621","article-title":"Universal screening with use of immunoglobulin G avidity for congenital cytomegalovirus infection","volume":"65","author":"Tanimura","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Britt, W.J. (2018). Maternal immunity and the natural history of congenital human cytomegalovirus infection. Viruses, 10.","DOI":"10.3390\/v10080405"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"18153","DOI":"10.1073\/pnas.0509201102","article-title":"Human cytomegalovirus virion protein complex required for epithelial and endothelial cell tropism","volume":"102","author":"Wang","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1128\/JVI.01910-07","article-title":"Characterization of the human cytomegalovirus gH\/gL\/UL128-131 complex that mediates entry into epithelial and endothelial cells","volume":"82","author":"Ryckman","year":"2008","journal-title":"J. Virol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"3796","DOI":"10.1016\/j.vaccine.2014.05.004","article-title":"Human cytomegalovirus gH\/gL\/UL128\/UL130\/UL131A complex elicits potently neutralizing antibodies in mice","volume":"32","author":"Wen","year":"2014","journal-title":"Vaccine"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"5983","DOI":"10.1016\/j.vaccine.2018.08.054","article-title":"Analysis of relationships between polymorphisms in the genes encoding the pentameric complex and neutralization of clinical cytomegalovirus isolates","volume":"36","author":"Kobayashi","year":"2018","journal-title":"Vaccine"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Schleiss, M.R., Permar, S.R., and Plotkin, S.A. (2017). Progress toward development of a vaccine against congenital cytomegalovirus infection. Clin. Vaccine Immunol., 24.","DOI":"10.1128\/CVI.00268-17"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Lilleri, D., Kabanova, A., Revello, M.G., Percivalle, E., Sarasini, A., Genini, E., Sallusto, F., Lanzavecchia, A., Corti, D., and Gerna, G. (2013). Fetal human cytomegalovirus transmission correlates with delayed maternal antibodies to gH\/gL\/pUL128-130-131 complex during primary infection. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0059863"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jiac.2016.12.001","article-title":"Immunoglobulin G avidity as a diagnostic tool to identify pregnant women at risk of congenital cytomegalovirus infection","volume":"23","author":"Kaneko","year":"2017","journal-title":"J. Infect. Chemother."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/1096-9071(20000201)63:2<135::AID-JMV1008>3.0.CO;2-P","article-title":"Use of recombinant glycoprotein antigens gB and gH for diagnosis of primary human cytomegalovirus infection during pregnancy","volume":"63","author":"Eggers","year":"2001","journal-title":"J. Med. Virol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1056\/NEJM200105033441804","article-title":"Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity","volume":"344","author":"Boppana","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1128\/CVI.00281-08","article-title":"Enzyme-linked immunosorbent assay method for detection of cytomegalovirus strain-specific antibody responses","volume":"16","author":"Novak","year":"2009","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_26","first-page":"881","article-title":"Prenatal diagnosis of congenital cytomegalovirus infection: Prospective study of 237 pregnancies at risk","volume":"95","author":"Liesnard","year":"2000","journal-title":"Obstet. Gynecol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1067\/mob.2000.106347","article-title":"Prenatal diagnosis of symptomatic congenital cytomegalovirus infection","volume":"183","author":"Guerra","year":"2000","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S1701-2163(16)34480-2","article-title":"Cytomegalovirus infection in pregnancy","volume":"32","author":"Yinon","year":"2010","journal-title":"J. Obstet. Gynaecol. Can."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/cid\/ciw707","article-title":"Prediction of congenital cytomegalovirus infection in high-risk pregnant women","volume":"64","author":"Tanimura","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2217\/fvl.12.8","article-title":"The immune response to human CMV","volume":"7","author":"Diamond","year":"2012","journal-title":"Future Virol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1182\/blood.V98.5.1358","article-title":"Tetramer-based quantification of cytomegalovirus (CMV)-specific CD8+ T lymphocytes in T-cell-depleted stem cell grafts and after transplantation may identify patients at risk for progressive CMV infection","volume":"98","author":"Gratama","year":"2001","journal-title":"Blood"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1084\/jem.20042384","article-title":"Protection from cytomegalovirus after transplantation is correlated with immediate early 1-specific CD8 T cells","volume":"201","author":"Bunde","year":"2005","journal-title":"J. Exp. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1093\/cid\/cix622","article-title":"Human cytomegalovirus-specific memory CD4_ T-cell response and its correlation with virus transmission to the fetus in pregnant women with primary infection","volume":"65","author":"Fornara","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1093\/cid\/civ561","article-title":"Strong cell-mediated immune response to human cytomegalovirus is associated with increased risk of fetal infection in primarily infected pregnant women","volume":"61","author":"Saldan","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1128\/JCM.03128-15","article-title":"Comparison of the cytomegalovirus (CMV) enzyme-linked immunosorbent spot and CMV QuantiFERON cell-mediated immune assays in CMV-seropositive and -seronegative pregnant and nonpregnant women","volume":"54","author":"Saldan","year":"2016","journal-title":"J. Clin. Microbiol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1128\/JCM.00561-16","article-title":"Cytomegalovirus (CMV) enzyme-linked immunosorbent spot assay but not CMV QuantiFERON assay is a novel biomarker to determine risk of congenital CMV infection in pregnant women","volume":"54","author":"Forner","year":"2016","journal-title":"J. Clin. Microbiol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1159\/000321346","article-title":"Imaging of fetal cytomegalovirus infection","volume":"29","author":"Malinger","year":"2011","journal-title":"Fetal Diagn. Ther."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/pd.4118","article-title":"A series of 238 cytomegalovirus primary infections during pregnancy: Description and outcome","volume":"33","author":"Picone","year":"2013","journal-title":"Prenat. Diagn."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"380.e1","DOI":"10.1016\/j.ajog.2007.09.052","article-title":"Ultrasound prediction of symptomatic congenital cytomegalovirus infection","volume":"198","author":"Guerra","year":"2008","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1053\/j.sult.2015.04.001","article-title":"Fetal brain magnetic resonance imaging findings in congenital cytomegalovirus infection with postnatal imaging correlation","volume":"36","author":"Averill","year":"2015","journal-title":"Semin. Ultrasound CT MRI"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jcv.2017.09.006","article-title":"Outcomes of congenital cytomegalovirus disease following maternal primary and non-primary infection","volume":"96","author":"Giannattasio","year":"2017","journal-title":"J. Clin. Virol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1080\/23744235.2017.1279344","article-title":"Primary versus non-primary maternal cytomegalovirus infection as a cause of symptomatic congenital infection\u2014Register-based study from Finland","volume":"49","author":"Puhakka","year":"2017","journal-title":"Infect. Dis."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1128\/CMR.00062-12","article-title":"The \u201csilent\u201d global burden of congenital cytomegalovirus","volume":"26","author":"Manicklal","year":"2013","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.jiac.2018.04.010","article-title":"Clinical factor associated with congenital cytomegalovirus infection in pregnant women with non-primary infection","volume":"24","author":"Yamada","year":"2018","journal-title":"J. Infect. Chemother."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jcv.2014.04.024","article-title":"Universal neonatal cytomegalovirus screening using saliva\u2014Report of clinical experience","volume":"60","author":"Barkai","year":"2014","journal-title":"J. Clin. Virol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0140-6736(00)04043-5","article-title":"Epidemiology of transmission of cytomegalovirus from mother to preterm infant by breastfeeding","volume":"357","author":"Hamprecht","year":"2001","journal-title":"Lancet"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1001\/jama.2010.423","article-title":"Dried blood spot real-time polymerase chain reaction assays to screen newborns for congenital cytomegalovirus infection","volume":"303","author":"Boppana","year":"2010","journal-title":"JAMA"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1056\/NEJMoa1006561","article-title":"Saliva polymerase-chain reaction assay for cytomegalovirus screening in newborns","volume":"364","author":"Boppana","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Vancor, E., and Shapiro, E.D. (2018). Results of a targeted screening program for congenital cytomegalovirus infection in infants who fail newborn hearing screening. J. Pediatr. Infect. Dis. Soc.","DOI":"10.1093\/jpids\/pix105"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.jpeds.2013.12.007","article-title":"Spectrum of disease and outcome in children with symptomatic congenital cytomegalovirus infection","volume":"164","author":"Dreher","year":"2014","journal-title":"J. Pediatr."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1056\/NEJMoa043337","article-title":"Congenital Cytomegalovirus Collaborating, G. Passive immunization during pregnancy for congenital cytomegalovirus infection","volume":"353","author":"Nigro","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref_52","unstructured":"Japanese Congenital Cytomegalovirus Infection Immunoglobulin Fetal Therapy Study (2012). A trial of immunoglobulin fetal therapy for symptomatic congenital cytomegalovirus infection. J. Reprod. Immunol., 915, 73\u201379."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"462.e1","DOI":"10.1016\/j.ajog.2016.04.003","article-title":"In utero treatment of congenital cytomegalovirus infection with valacyclovir in a multicenter, open-label, phase II study","volume":"215","author":"Ghout","year":"2016","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1056\/NEJMoa1310214","article-title":"A randomized trial of hyperimmune globulin to prevent congenital cytomegalovirus","volume":"370","author":"Revello","year":"2014","journal-title":"N. Engl. J. Med."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/19\/12\/3760\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:32:19Z","timestamp":1760196739000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/19\/12\/3760"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,27]]},"references-count":54,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["ijms19123760"],"URL":"https:\/\/doi.org\/10.3390\/ijms19123760","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,27]]}}}